Silence Therapeutics: Of The Current Report On Form 8k Filed On December 15, 2025 (the “original Form 8k”) To Disclose Information Regarding Material Modifications To A Material Compensatory Plan, Contract Or Arrangement As To Which A Named Executive Officer Of The Registrant Participates That Were Effected Pursuant To An Agreement Entered Into Subsequent To The Filing Of The Original Form 8k. No Other Changes Have Been Made To The Original Form 8k
| Mostrar el artículo completo |
|
Esta funcionalidad está disponible solamente para los usuarios autorizados.
|
-
Nombre completoSilence Therapeutics PLC
-
País de registroUnited Kingdom
-
IndustriaPharmaceutical Preparation and Biotechnology
-
M/S&P/F
*** /*** /***